Show simple item record

Diagnosis and categorization of malignant effusions: A 6‐year review from a single academic institution

dc.contributor.authorLew, Madelyn
dc.contributor.authorCantley, Richard
dc.contributor.authorHeider, Amer
dc.contributor.authorJing, Xin
dc.date.accessioned2021-04-06T02:14:08Z
dc.date.available2022-06-05 22:14:07en
dc.date.available2021-04-06T02:14:08Z
dc.date.issued2021-05
dc.identifier.citationLew, Madelyn; Cantley, Richard; Heider, Amer; Jing, Xin (2021). "Diagnosis and categorization of malignant effusions: A 6‐year review from a single academic institution." Diagnostic Cytopathology 49(5): 615-621.
dc.identifier.issn8755-1039
dc.identifier.issn1097-0339
dc.identifier.urihttps://hdl.handle.net/2027.42/167109
dc.description.abstractBackgroundCytologic detection of malignant cells in pleural, peritoneal, or pericardial effusion most likely indicates advanced stage of malignant disease. There are a few studies updating the categorization of malignant effusions.MethodsThe electronic pathology database was searched to identify consecutive cases of malignant effusion during a 6‐year period. Patient age and gender, origins of known malignancy, and cytologic diagnoses were recorded and summarized.ResultsA total of 1059 specimens included 561 (53%) pleural, 441 (41.6%) peritoneal, and 57 (5.4%) pericardial fluids. Most of the pleural (516, 92.0%), peritoneal (418, 94.8%), and pericardial (53, 93.0%) specimens were derived from patients with a single known malignancy. More common origins involving pleural fluid were lung (152, 27.1%) followed by breast (103, 18.4%) and gastrointestinal tract (76, 13.5%). The most common etiology for women and men was breast (102, 30.8%) and lung (67, 36.2%), respectively. More common origins involving peritoneal fluid were gastrointestinal (158, 35.8%) and gynecologic (156, 35.4%) tracts, and breast (46, 10.4%). The most common etiology for women and men was Mullerian (156, 55.5%) and gastrointestinal tract (94, 68.6%), respectively. Most common origins involving the pericardial fluid were breast (20, 37.7%) and lung (17, 29.8%). Breast and lung were the most common etiology for women (20, 57.1%) and men (8, 44.4%), respectively.ConclusionsBreast and lung remain to be the most common origin of both malignant pleural and pericardial effusion for women and men, respectively. The most common origin involving peritoneal effusion is Mullerian for women and gastrointestinal tract for men.
dc.publisherJohn Wiley & Sons, Inc.
dc.subject.otherperitoneal fluids
dc.subject.othercytology of effusions
dc.subject.otherpleural fluids
dc.subject.othermalignant effusions
dc.subject.otherpericardial fluids
dc.titleDiagnosis and categorization of malignant effusions: A 6‐year review from a single academic institution
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPathology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/167109/1/dc24433.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/167109/2/dc24433_am.pdf
dc.identifier.doi10.1002/dc.24433
dc.identifier.sourceDiagnostic Cytopathology
dc.identifier.citedreferenceLi JJX, Chan WC, Chau HHL, Wu C, Tse GM. Cytologic diagnosis of metastatic malignant phyllodes tumor of the breast in pleural effusion. Diagn Cytopathol. 2019; 47 ( 6 ): 599 ‐ 602.
dc.identifier.citedreferenceDermawan JKT, Policarpio‐Nicolas ML. Malignancies in pleural, peritoneal, and pericardial effusions: a 17‐year single‐institution review from 30 085 specimens. Arch Pathol Lab Med. 2020.
dc.identifier.citedreferenceDas DK. Serous effusions in malignant lymphomas: a review. Diagn Cytopathol. 2006; 34 ( 5 ): 335 ‐ 347.
dc.identifier.citedreferenceKhalbuss WE, Yang H, Lian Q, Elhosseiny A, Pantanowitz L, Monaco SE. The cytomorphologic spectrum of small‐cell carcinoma and large‐cell neuroendocrine carcinoma in body cavity effusions: a study of 68 cases. Cytojournal. 2011; 8: 18.
dc.identifier.citedreferenceDavion S, Rohan S, Nayar R, Kulesza P. Metastatic chromophobe renal cell carcinoma in pleural fluid cytology: review of literature and report of a case. Diagn Cytopathol. 2012; 40 ( 9 ): 826 ‐ 829.
dc.identifier.citedreferenceGupta S, Sodhani P, Jain S. Cytomorphological profile of neoplastic effusions: an audit of 10 years with emphasis on uncommonly encountered malignancies. J Cancer Res Ther. 2012; 8 ( 4 ): 602 ‐ 609.
dc.identifier.citedreferenceDragoescu EA, Liu L. Pericardial fluid cytology: an analysis of 128 specimens over a 6‐year period. Cancer Cytopathol. 2013; 121 ( 5 ): 242 ‐ 251.
dc.identifier.citedreferenceLew M, Pang JC, Roh MH, Jing X. Cytologic features and immunocytochemical profiles of malignant effusions with metastatic papillary thyroid carcinoma: a case series from a single institution. Acta Cytol. 2015; 59 ( 5 ): 412 ‐ 417.
dc.identifier.citedreferencePolicarpio‐Nicolas ML, Avery DL, Hartley T. Merkel cell carcinoma presenting as malignant ascites: a case report and review of literature. Cytojournal. 2015; 12: 19.
dc.identifier.citedreferenceHarbhajanka A, Brickman A, Park JW, Reddy VB, Bitterman P, Gattuso P. Cytomorphology, clinicopathologic, and cytogenetics correlation of myelomatous effusion of serous cavities: a retrospective review. Diagn Cytopathol. 2016; 44 ( 9 ): 742 ‐ 747.
dc.identifier.citedreferenceRaymond SLT, Au K, Fu R, Tauchi‐Nishi PS. Metastatic genitourinary cancer diagnosed by body fluid cytology: clinicopathologic and cytomorphologic correlation. J Am Soc Cytopathol. 2017; 6 ( 2 ): 48 ‐ 58.
dc.identifier.citedreferenceSaab J, Hoda RS, Narula N, et al. Diagnostic yield of cytopathology in evaluating pericardial effusions: clinicopathologic analysis of 419 specimens. Cancer Cytopathol. 2017; 125 ( 2 ): 128 ‐ 137.
dc.identifier.citedreferenceRooper LM, Ali SZ, Olson MT. A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: a retrospective analysis of 2540 cases. Cancer Cytopathol. 2014; 122 ( 9 ): 657 ‐ 665.
dc.identifier.citedreferenceRooper LM, Ali SZ, Olson MT. A minimum volume of more than 60 mL is necessary for adequate cytologic diagnosis of malignant pericardial effusions. Am J Clin Pathol. 2016; 145 ( 1 ): 101 ‐ 106.
dc.identifier.citedreferenceDadhich H, Toi PC, Siddaraju N, Sevvanthi K. A comparative analysis of conventional cytopreparatory and liquid based cytological techniques (sure path) in evaluation of serous effusion fluids. Diagn Cytopathol. 2016; 44 ( 11 ): 874 ‐ 879.
dc.identifier.citedreferenceLee YM, Hwang JY, Son SM, et al. Comparison of diagnostic accuracy between CellprepPlus(R) and ThinPrep(R) liquid‐based preparations in effusion cytology. Diagn Cytopathol. 2014; 42 ( 5 ): 384 ‐ 390.
dc.identifier.citedreferenceSundling KE, Cibas ES. Ancillary studies in pleural, pericardial, and peritoneal effusion cytology. Cancer Cytopathol. 2018; 126 ( suppl 8 ): 590 ‐ 598.
dc.identifier.citedreferencePorcel JM. Diagnosis and characterization of malignant effusions through pleural fluid cytological examination. Curr Opin Pulm Med. 2019; 25 ( 4 ): 362 ‐ 368.
dc.identifier.citedreferenceSiddiqui MT, Schmitt F, Churg A. Proceedings of the American Society of Cytopathology companion session at the 2019 United States and Canadian Academy of Pathology annual meeting, part 2: effusion cytology with focus on theranostics and diagnosis of malignant mesothelioma. J Am Soc Cytopathol. 2019; 8 ( 6 ): 352 ‐ 361.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.